US Broker Ratings

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Insights into a Challenging Market Landscape and Growth Potential

Fulgent Genetics, Inc. (NASDAQ: FLGT) stands at a pivotal intersection in the diagnostics and research industry, particularly as the healthcare sector continues to evolve post-pandemic. With its current market capitalization..

Humacyte, Inc. (HUMA) Stock Analysis: Unlocking a 267% Potential Upside in the Biotech Sector

Investors with an eye on Humacyte, Inc. (NASDAQ: HUMA) may find themselves at the intersection of innovation and opportunity in the burgeoning biotechnology sector. With a market capitalization of $139.7..

OrthoPediatrics Corp. (KIDS) Investor Outlook: Analyzing a 25% Potential Upside in the Pediatric Orthopedic Market

OrthoPediatrics Corp. (NASDAQ: KIDS) stands as a unique player in the healthcare sector, focusing on the often underrepresented niche of pediatric orthopedics. With a market capitalization of $566.32 million, the..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a 219.77% Potential Upside

REGENXBIO Inc. (NASDAQ: RGNX), a key player in the biotechnology sector, is drawing attention with its staggering 219.77% potential upside. As a clinical-stage biotechnology company, REGENXBIO is focused on developing..

Community Health Systems, Inc. (CYH) Stock Analysis: Exploring the 14.77% Potential Upside for Investors

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates a network of general acute care hospitals across the United States. With its headquarters situated in..

Nutex Health Inc. (NUTX) Stock Analysis: Potential 35.74% Upside Captivates Investors

Nutex Health Inc. (NUTX), a notable player in the healthcare sector specializing in medical care facilities, presents a compelling investment opportunity with a potential upside of 35.74%. Headquartered in Houston,..

Geron Corporation (GERN) Stock Analysis: Unveiling a Potential 251% Upside in the Biotech Sector

Geron Corporation (NASDAQ: GERN), a key player in the biotechnology sector, is capturing investor attention with its promising therapeutic pipeline and the potential for significant stock appreciation. As a commercial-stage..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Challenges with Growth in Cancer Genomics

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. Based in Fremont, California, this innovative company specializes in advanced cancer genomic..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising 71.35% Potential Upside Sparks Investor Interest

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biotechnology firm, is making waves in the healthcare sector with its innovation-driven approach to immunology-based therapies. Headquartered in Waltham, Massachusetts, Zenas BioPharma is..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring a 50% Upside Potential

Investors keen on the healthcare sector, particularly in the niche of neurodegenerative disease treatment, should closely consider Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX). This U.S.-based pharmaceutical company has positioned itself as..

Neuropace, Inc. (NPCE) Stock Analysis: Navigating a 52% Potential Upside in the Medical Device Sector

Neuropace, Inc. (NASDAQ: NPCE) stands at an intriguing juncture in the healthcare sector, particularly within the dynamic medical devices industry. With a market capitalization of $451.36 million, this United States-based..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Can a 42.86% Upside Revitalize Investor Interest?

Organogenesis Holdings Inc. (NASDAQ: ORGO), a regenerative medicine company based in Canton, Massachusetts, is currently a focal point for investors in the healthcare sector. With its market cap at $180.14..

COMPASS Pathways Plc (CMPS): Investor Outlook on 98.74% Potential Upside in Mental Health Innovation

COMPASS Pathways Plc, trading under the ticker CMPS, is capturing attention in the healthcare sector with its promising focus on mental health treatments. Operating within the medical care facilities industry,..

Septerna, Inc. (SEPN) Stock Analysis: Unveiling a 42.5% Upside Potential with Strong Buy Ratings

Septerna, Inc. (NASDAQ: SEPN), a trailblazer in the biotechnology sector, has caught the attention of investors with its promising pipeline and robust analyst endorsements. With a market capitalization of $1.78..

Orthofix Medical Inc. (OFIX) Stock Analysis: A 41% Potential Upside Awaits Investors

Orthofix Medical Inc. (NASDAQ: OFIX) has emerged as a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $375.15 million, this U.S.-based..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Unpacking the 76.70% Potential Upside

Cogent Biosciences, Inc. (NASDAQ: COGT) has captured significant attention in the biotechnology investment sphere, primarily due to its robust pipeline and considerable potential upside. As a clinical-stage biotech firm headquartered..

SIGA Technologies Inc. (SIGA) Stock Analysis: Is the Healthcare Sector’s Underdog Poised for a Comeback?

SIGA Technologies Inc. (NASDAQ: SIGA), a player in the niche healthcare market, primarily focuses on developing antiviral products. Despite being a commercial-stage pharmaceutical company with a market cap of $240.7..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Strong Buy Ratings Signal Potential 49% Upside

Relay Therapeutics, Inc. (NASDAQ: RLAY) is capturing the attention of investors within the healthcare sector, particularly in the biotechnology industry. With a market capitalization of $4.05 billion, this Cambridge, Massachusetts-based..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring the 105.71% Potential Upside Amidst Market Volatility

Tilray Brands, Inc. (NASDAQ: TLRY) stands at a fascinating crossroads, promising significant potential upside for investors willing to navigate the volatility of the cannabis sector. With a striking 105.71% potential..

Inventiva S.A. (IVA) Stock Analysis: Unveiling a Potential 324% Upside in Biotech

Investors intrigued by high potential returns may want to keep an eye on Inventiva S.A. – American Depositary Shares (IVA), a French biotechnology firm with a current market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds